© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Reflector
Articles
A FAB Opportunity Emerging for Europe’s Drugmakers
New EU initiative aims to curve shortage of vaccines and therapies.
Advanced Therapy Makers Claim a Double Barrier Over Access
Treatment availability for rare disease patients under fire in Europe.
Contention Swirls Around COVID Patent Waivers
Report claims an imbalance in influence of tech-transfer decisions.
COVID Blame Games Give Way to Lesson Learning
Summits, proposals outline advice on response to future pandemics.
Bringing a European Focus to Drug Import Vulnerabilities
Pandemic triggers urgency around supply chain initiatives.
What’s to Come for HTA Legislation and Collaboration?
The progress and stumbling blocks in building a formal EU system.
Long-View Innovation Hopes for Pharma Policy in the EU
Draft plan looks beyond the immediate European health challenges.
COVID-19 Catalyzing Changes in European Medicines Regulation
Latest proposal explores boosting the powers of the EMA.
The Fight for Orphan Drug Research Reform in Europe
Can private sector serve public interests in battling rare diseases?
Following Through on ‘New-Era’ Boasts for European Health Policy
EU tasked with translating bold declarations into reality.